Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H2 synthases by ibuprofen, naproxen, and indomethacin

This publication has 38 references indexed in Scilit:

• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
  Published by Elsevier ,2002
• New insights into the role of COX 2 in inflammation
  Journal of Molecular Medicine, 2000
• CYCLOOXYGENASES 1 AND 2
  Annual Review of Pharmacology and Toxicology, 1998
• Pharmacology of Prostaglandin Endoperoxide Synthase Isozymes‐1 and‐2^a
  Annals of the New York Academy of Sciences, 1994
• NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
  Prostaglandins, 1994
• Cloning and Expression of Rat Prostaglandin Endoperoxide Synthase (Cyclooxygenase)-2 cDNA
  Biochemical and Biophysical Research Communications, 1993
• Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their Expression
  Archives of Biochemistry and Biophysics, 1993
• The eicosanoids and their biochemical mechanisms of action
  Biochemical Journal, 1989
• Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents.
  Proceedings of the National Academy of Sciences, 1981
• Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.
  Proceedings of the National Academy of Sciences, 1975